Market power and state costs of HIV/AIDS drugs

  title={Market power and state costs of HIV/AIDS drugs},
  author={Arleen A Leibowitz and Neeraj Sood},
  journal={International Journal of Health Care Finance and Economics},
We examine whether U.S. states can use their market power to reduce the costs of supplying prescription drugs to uninsured and underinsured persons with HIV through a public program, the AIDS Drug Assistance Program (ADAP). Among states that purchase drugs from manufacturers and distribute them directly to clients, those that purchase a greater volume pay lower average costs per prescription. Among states depending on retail pharmacies to distribute drugs and then claiming rebates from… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper


Publications referenced by this paper.
Showing 1-6 of 6 references

National ADAP Monitoring Project

N.A.L. Singleton

Pharmaceuticals in U.S. health care: determinants of quantity and price.

The journal of economic perspectives : a journal of the American Economic Association • 2002
View 1 Excerpt

Soaring prices , soaring sales

J. Kates, M. Penner, B. Crutsinger-Perry, AW. Singleton Leggoe, N.
GMHC Treatment Issues • 1998

Similar Papers

Loading similar papers…